엔비노 메디컬(NVNO)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $8.99 (+2.24%), 시가총액 $0.01B, 52주 최저~최고 $0.31 ~ $13.00.
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was forme
엔비노 메디컬의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
엔비노 메디컬의 현재 주가는 $8.99 (+2.24%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
엔비노 메디컬의 시가총액은 약 $0.01B입니다.
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the Unit